Oncogenic functions of ARTEMIN in ER negative mammary carcinoma
2013 doctoral thesis by Arindam Banerjee at University of Auckland
Press Enter · cited answer in seconds
0 sources
Oncogenic functions of ARTEMIN in ER negative mammary carcinoma
Summary
Oncogenic functions of ARTEMIN in ER negative mammary carcinoma is a doctoral thesis[1].
Key Facts
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma authored Arindam Banerjee[2].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's instance of is recorded as doctoral thesis[3].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's publisher is recorded as ResearchSpace@Auckland[4].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's copyright license is recorded as Creative Commons Attribution-NonCommercial-ShareAlike 3.0 New Zealand[5].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's country of origin is recorded as New Zealand[6].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's publication date is recorded as +2013-00-00T00:00:00Z[7].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's work available at URL is recorded as https://researchspace.auckland.ac.nz/handle/2292/21237[8].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's Handle ID is recorded as 2292/21237[9].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's title is recorded as Oncogenic functions of ARTEMIN in ER negative mammary carcinoma[10].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's copyright holder is recorded as Arindam Banerjee[11].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's thesis submitted to is recorded as University of Auckland[12].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's on focus list of Wikimedia project is recorded as NZThesisProject[13].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's copyright status is recorded as copyrighted[14].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's online access status is recorded as open access[15].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's thesis committee member is recorded as Peter Edward Lobie[16].
- Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's thesis committee member is recorded as Dong-Xu Liu[17].
Body
Designation and Status
Oncogenic functions of ARTEMIN in ER negative mammary carcinoma's instance of is recorded as doctoral thesis[3].